G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
49.70
-0.70 (-1.39%)
Aug 15, 2025, 1:30 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 3.17 billion as of August 15, 2025. Its market cap has decreased by -4.38% in one year.
Market Cap
3.17B
Enterprise Value
2.71B
Revenue
294.26M
Ranking
n/a
PE Ratio
23.56
Stock Price
49.70
Market Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has increased from 2.62B to 3.17B, an increase of 20.92%. That is a compound annual growth rate of 1.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 3.17B | -5.17% |
Dec 31, 2024 | 3.34B | -2.92% |
Dec 29, 2023 | 3.44B | 15.73% |
Dec 30, 2022 | 2.97B | 90.71% |
Dec 30, 2021 | 1.56B | -19.66% |
Dec 31, 2020 | 1.94B | -3.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 208.61B |
PharmaEssentia | 169.30B |
Bora Pharmaceuticals Co., LTD. | 94.94B |
Lotus Pharmaceutical | 53.91B |
Oneness Biotech | 32.23B |
Polaris Group | 27.47B |
Lumosa Therapeutics | 27.18B |
Center Laboratories | 26.42B |